England - London • TMT (technology, media and telecoms)
Elkington + Fife LLP
Elkington + Fife LLP has demonstrable expertise in EPO opposition and appeals work, and it offers its pharmaceutical clients support with the entire lifecycle of their patent mandates; the group represents four of the largest pharmaceutical companies in the world. London-based senior partner Richard Gillard, praised as ‘tenacious and knowledgeable’, sits at the helm of the chemistry and life sciences practice with strong experience in opposition and appeals work and, while Nick Ertl in Sevenoaks chairs the electrical and mechanical group. Ertl is skilled in patent drafting for corporate clients, including for medical imaging, display technology, electronic circuits, optical communications equipment, and many more products. James Anderson (Sevenoaks) is highly adept at advising clients on mechanical, materials, and engineering patents, and London-based Jens Grabenstein is growing the firm’s biotechnology offering.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Elkington and Fife are somewhat of a hidden gem amongst the leading UK patent firms. They are successful and great to work with.’
‘Richard Gillard and Oliver Kingsbury stand out. Richard is tenacious and knowledgeable, and Oliver is hugely experienced and develops winning arguments.’
‘The team is both knowledgeable and very responsive to inquiries.'
‘Robert O'Callaghan has consistently high availability for urgent matters, and provides proactive pragmatic recommendations to cost effectively move matters forward.'
‘Robert O'Callaghan is an in-depth expert in global navigation satellite systems!’
Key clients
- AbbVie
- Accord Healthcare
- Alcon Laboratories
- Amgen
- Analog Devices
- Apeel Sciences
- Astex
- Balfour Beatty
- Bayer
- Beam Therapeutics
- Benuvia Therapeutics
- Bial
- Celleron Therapeutics
- Corning Incorporated
- Coventry City Council
- Dana Farber Cancer Institute
- Deka Research & Development
- Fujifilm Speciality Ink Systems
- Glowbuzzer
- Graphene Composites
- IBM
- Imagination Technologies
- Instituto de Medicina Molecular
- Fujifilm
- Kiniksa
- Kyowa
- Malvern Panalytical
- Merck Pharmaceuticals
- Merck KGaA
- Microline Surgical
- Milliken & Company
- Mundipharma
- NantKwest
- Nestlé
- NHS
- Novartis
- Philips
- Pfizer
- Polpharma
- Procter & Gamble
- ReNeuron
- Rothwell Figg Ernst & Manbeck
- Sandoz
- Sanofi
- Samsung
- Serimmune
- SLAMCore
- Solvay
- Strategic Support
- Takeda
- TempEasy
- Teva
- The Coca-Cola Company
- The Dow Chemical Company
- Thrive Earlier Detection
- Torbay and South Devon NHS Foundation Trust
- u-blox AG
- Universal Quantum
- University of Kent
- Versuni
- Viatris
- Visterra
- VitaFlo
- Wood Phillips
- Xylem
- Zymeworks
Work highlights
- Advising IBM UK on drafting and prosecuting patent applications for AI Intelligence and machine learning inventions.
- Assisting Novartis with its prosecution proceedings and strategy regarding its entire immune-checkpoint-related antibody portfolio.
- Representing Sanofi as an opponent in opposition proceedings against GSK covering RNA vaccines.
Practice head
The lawyer(s) leading their teams.
Richard Gillard, Nick Ertl